羧肽酶B2(CPB2)重组蛋白
Recombinant Carboxypeptidase B2 (CPB2)
TAFI; CPU; PCPB; Thrombin Activatable Fibrinolysis Inhibitor; Plasma Carboxypeptidase B; Carboxypeptidase U
- 编号RPA615Mu03
- 物种Mus musculus (Mouse，小鼠) 相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量23.4kDa
- 实际分子量23kDa(差异分析请参阅说明书)
- 片段与标签Pro187~Lys327 (Accession # Q9JHH6) with N-terminal His Tag
- 缓冲液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 90%
- 等电点8.73
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 840 ¥ 2100 ¥ 4200 ¥ 12600 ¥ 31500
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
SDS-PAGE图
-
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Mus musculus (Mouse，小鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPA615Mu01 | 羧肽酶B2(CPB2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA615Mu03 | 羧肽酶B2(CPB2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA615Mu02 | 羧肽酶B2(CPB2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA615Mu03 | 羧肽酶B2(CPB2)多克隆抗体 | WB; IHC; ICC; IP. |
| PAA615Mu02 | 羧肽酶B2(CPB2)多克隆抗体 | WB; IHC; ICC; IP. |
| PAA615Mu01 | 羧肽酶B2(CPB2)多克隆抗体 | WB; IHC; ICC; IP. |
| LAA615Mu71 | 羧肽酶B2(CPB2)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| LAA615Mu81 | 羧肽酶B2(CPB2)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| SEA615Mu | 羧肽酶B2(CPB2)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA615Mu | 羧肽酶B2(CPB2)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Taiwan J Obstet Gynecol. | Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients [Pubmed:26927250] |
| Experiental And Therapeutic Medicine | Plasma proteins as potential targets of abnormal Savda syndrome in asthma patients treated with unique Uighur prescription [pubmed:28672924] |
| Clinics and Research in Hepatology and Gastroenterology | Thrombin activatable fibrinolysis inhibitor as an indicator of the severity of acute pancreatitis [Pubmed:22230218] |
留言咨询